Building long-term synergistic partnerships
We partner with a wide range of innovators and entrepreneurs, life science organisations, disease charities, pharmaceutical and biotechnology companies.
Our dedicated Business Development team focus on both
in-licensing and out-licensing:
The strength of our partnerships is impacting the pace of global discovery from research through to positive outcomes for human health.
We have a comprehensive range of partnering models that we employ to create optimal deal structures for our partners.
At the end of her first week at Abcam, Emma shares her thoughts about the evolution of the biotech sector, the effect of COVID-19 on the industry, and her views about Abcam’s position in this ever-changing landscape.